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In previous studies with hyperimmune rabbit sera and monoclonal antibodies against the P1 protein of
Mycoplasma pneumoniae, we obtained evidence of a shared antigenic determinant with a single protein of
Mycoplasma genitalium. Because of biologic and morphologic similarities between these two human
Mycoplasma species, attempts were made to characterize this cross-reacting protein of M. genitalium
(designated MgPa). The protein was surface exposed and had an estimated molecular size of 140 kilodaltons.
Electron microscopy with monoclonal antibodies produced against either MgPa or P1 demonstrated that MgPa
is located over the surface of the terminal structure of M. genitalium which is covered by a nap layer. These
immunologic and morphologic findings suggest that the MgPa protein of M. genitalium could be the
counterpart of the P1 protein of M. pneumoniae.
Mycoplasma genitalium is a new mycoplasma isolated
from the urethral specimens of human patients with nongon-
ococcal urethritis (23, 30, 31). Although technical problems
have impeded large-scale surveys for the prevalence of the
organism, seroepidemiologic data and experimental infec-
tions suggest its pathogenicity. Antibodies specific to M.
genitalium, but not to Chlamydia trachomatis and
Mycoplasma hominis, have been demonstrated in 40% of 31
women with acute pelvic inflammatory disease (29). When
inoculated intraurethrally, this organism induced urethritis
in young male chimpanzees (28). The organism could be
reisolated from the experimentally infected animals for at
least 13 weeks, and the chimpanzees developed a marked
antibody response. This evidence implicates M. genitalium
in the etiology of human genitourinary tract disease.
Ultrastructural studies indicated that M. genitalium pos-
sesses a differentiated termiinal structure covered by a
peplomer-like nap (30). Furthermore, adherence of M.
genitalium to Vero cell membranes appeared to be mediated
by the nap area (31). This evidence suggests that M.
genitalium may possess an attachment mechanism similar to
that described earlier for Mycoplasma pneumoniae (2, 9, 12,
13). This possibility is supported by previous findings that
M. genitalium shares extensive serologic cross-reactivity
with M. pneumoniae (3, 11, 21) and that a monoclonal
antibody specific to the P1 protein of M. pneumoniae was
reactive with a single protein of M. genitalium by immuno-
blotting (7). In the present study, further characterization of
this cross-reacting protein by immunological and ultrastruc-
tural means is described.
MATERIALS AND METHODS
Growth of mycoplasmas. M. genitalium G-37 (ATCC
33530) was purchased from the American Type Culture
Collection (Rockville, Md.). M. pneumoniae M129-B12
(ATCC 29342) was from our stock. Monolayer cultures of
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mycoplasmas were grown in Edward-Hayflick medium in
glass prescription bottles as previously described (13). Or-
ganisms were harvested by rinsing confluent monolayers
with 0.01 M phosphate-buffered saline (PBS, pH 7.2) fol-
lowed by scraping into ice-cold PBS and pelleting by cen-
trifugation.
Antisera and monoclonal antibodies. Hyperimmune rabbit
antisera to M. genitalium and M. pneumoniae were pro-
duced by subcutaneous injection of washed whole organisms
(approximately 1 mg of protein) emulsified in complete
Freund adjuvant followed by three alternate-week booster
injections in incomplete Freund adjuvant. The procedures
described by Shulman et al. (27) were used to produce
monoclonal antibodies against M. genitalium proteins.
Briefly, splenic cells from BALB/c mice i.mmunized with
whole M. genitalium organisms were hybridized with my-
eloma tells SP2/0 Agl4 (ATCC CRL-1581). Hybridomas
producing antibodies against M. genitalium were screened
with a solid-phase radioimmunoassay (17), and those specific
to particular proteins were identified with Western immuno-
blotting (16). '251-labeled immunoglobulins were prepared by
the chloramine T method (10). Monoclonal antibodies spe-
cific to the P1 protein ofM. pneumoniae were available from
our previous studies (7, 12, 15). Preimmune and immune sera
from a young adult chimpanzee expermentally infected with
M. genitalium were also available from a previous study
(28).
Identification of M. genitalium surface proteins. Surface
proteins of M. genitalium were identified as described re-
cently by Engleberg et al. (8) by using antibodies absorbed
onto freshly propagated organisms in combination with
immunoblotting, instead of iodination (18). Briefly, mono-
layer culture grown to confluence in a 96-oz (ca. 2.839-liter)
prescription bottle was washed three times with PBS. To
this, 0.2 ml of hyperimmune rabbit antiserum to M.
genitalium diluted in 20 ml of PBS was added, and the
culture was stored at 4°C overnight. The supernatant was
discarded, and the mycoplasma monolayer was thoroughly
washed with PBS. After the final wash, 2.0 ml of elution
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buffer (0.2 M NaCl, 0.2 M glycine, pH 2.8) was added. The
bottle was incubated at room temperature for 30 min with
gentle rocking to release the absorbed antibodies. The
elution buffer containing the released antibodies was recov-
ered, the pH was titrated immediately to 7.5 with 2.0 M Tris,
and the mixture was centrifuged at 27,000 x g for 30 min at
4°C. The recovered antibodies were used in immunoblotting
for the identification of M. genitalium surface antigens.
Trypsin treatment of M. genitalium. As described previ-
ously, the age of the mycoplasma monolayer cultures was
critical to the effectiveness of enzyme treatment (13); cul-
tures incubated for 24 to 36 h were found to be optimal. The
growth medium was decanted, and the monolayers were
washed with PBS before receiving 20 ml of minimal essential
medium. Crystalline trypsin (type XI, diphenyl carbamyl
chloride treated, 7,500 BAEE units per mg of protein; Sigma
Chemical Co., St. Louis, Mo.) was then introduced to final
concentrations ranging from 25 to 500 jig/ml. Trypsin-treated
cultures were incubated at 37°C for 0 to 30 min, and the
reaction was terminated by the addition of 2 ml of fetal calf
serum. Control cultures were treated similarly, except that
trypsin was omitted. The monolayer cultures were then
washed three times with PBS, scraped into 2.0 ml of PBS,
and processed for sodium dodecyl sulfate-gel electrophoresis.
Sodium dodecyl sulfate-gel electrophoresis and Western
blotting. The procedures for sodium dodecyl sulfate-gel
electrophoresis of mycoplasma proteins and preparation of
Western blots were those used previously (16).
Electron microscopy and immunostaining. The morphology
ofM. genitalium was examined by electron microscopy with
both negative staining procedures and thin sectioning as
described by Tully et al. (31). For negative staining, the
young monolayer culture was scraped from the glass bottle
into a small amount of fresh medium and pelleted in a
Brinkmann microfuge. The pellet was suspended in 1%
ammonium acetate. A small drop was applied to an electron
microscope grid and stained with 2% ammonium molybdate
as described by Cole and Popkin (5). For immunostaining,
M. genitalium grown on cover slips in 24-well microtiter
plates was fixed with 2.0 ml of 5% formaldehyde in PBS for
2 h, washed thoroughly with PBS, and incubated with 1.0 ml
of monoclonal antibody Mg-209 (heat-inactivated ascites
fluid diluted 1:20 in PBS containing 2% immunoglobulin
G-free horse serum) overnight at 4°C. The cover slips were
washed extensively again with PBS and incubated with 1.0
ml ferritin-conjugated goat antibody to mouse immunoglob-
ulin G (Cappel-Worthington Biochemicals, Malvern, Pa.)
diluted 1:20 or 1:100 in PBS containing 2% immunoglobulin
G-free horse serum for 6 h at 4°C. After extensive washing
with cold PBS, the treated monolayers of mycoplasmas were
then fixed with a solution of 2% glutaraldehyde and 2%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.2) over-
night, washed three times with phosphate buffer with 6.8%
sucrose, and then subjected to secondary fixation with 1%
osmium tetroxide in phosphate buffer for 1 h at room
temperature. After dehydration the samples were embedded
in Luft's Epon 812. Thin sections were cut with an LKB
Huxley ultramicrotome and stained with 5% uranyl acetate
followed by Reynolds lead citrate. Electron microscopy was
carried out with a Zeiss model EM-1OA electron microscope
at an accelerating voltage of 60 kV.
RESULTS
Monoclonal antibodies specific to MgPa protein of M.
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FIG. 1. Monoclonal antibodies specific to MgPa protein of M.
genitalium. Western blots of M. genitalium proteins separated on a
7% sodium dodecyl sulfate gel were incubated with rabbit hyperim-
mune serum and imaged with "25I-labeled goat anti-rabbit immuno-
globulin G (lane 1) or incubated with monoclonal antibody Mg-209
(lane 2), Mg-124 (lane 3), Mg-182 (lane 4), Mg-229 (lane 5), or
Mg-240 (lane 6) and then imaged with l25l-labeled goat anti-mouse
immunoglobulins. In lanes 7 and 8, two additional monoclonal
antibodies, Mg-199 and Mg-167, which reacted with two M.
genitalium proteins other than MgPa, were included as specificity
controls. The absence of visible bands at the position of 140 kDa in
lanes 7 and 8 indicates that the recognization of MgPa by monoclo-
nal antibodies in lanes 2 through 6 is specific. Molecular masses
(kDa) of protein standards are indicated by numbers.
Mg-124, Mg-182, Mg-229, and Mg-240, were specifically
reactive with MgPa by immunoblotting (Fig. 1, lanes 2
through 6). The variable intensity of these monoclonal
antibody reactions may be related to their concentration,
affinity of binding, or specificity for different epitopes of the
MgPa molecule. Monoclonal antibodies Mg-199 (lane 7) and
Mg-169 (lane 8), which react with two other M. genitalium
protein bands with molecular masses estimated 66 and 57
kilodaltons (kDa), respectively, were included as controls.
The absence of visible bands at the position of 140 kDa in
lanes 7 and 8 indicates that the recognization of MgPa by
monoclonal antibodies in lanes 2 through 6 is specific.
Monoclonal antibody Mg-209 (lane 2), because of its strong
reactivity, was chosen later for immunostaining to determine
the location of the MgPa on the organism.
Identification of surface-exposed proteins. One of the re-
quirements to support our hypothesis that the MgPa protein
of M. genitalium may serve the same function as P1 of M.
pneumoniae is that MgPa must be a surface component. To
examine this, rabbit antiserum was placed on monolayers of
glass-attached M. genitalium organisms. After washing,
surface-bond antibodies eluted from the monolayer culture
were used to probe Western blots of M. genitalium proteins.
Eleven major protein bands including MgPa were identified
by the surface-bound antibodies (Fig, 2, lane 1), whereas the
unabsorbed rabbit antiserum recognized many more bands
(lane 2). None of these protein bands reacted with normal
preimmune rabbit serum (lane 3). These results indicate that
MgPa is one of the surface-exposed proteins of M.
genitalium.
Sensitivity of MgPa to trypsin treatment. Evidence that
MgPa is a surface protein was extended by determining
whether it could be removed by trypsin treatment. Prelimi-
nary experiments indicated that MgPa is more resistant to
trypsin treatment than the P1 protein of M. pneumoniae
(removed by 25 ,ug of trypsin per ml for 15 min). However,
when the concentration of trypsin was increased up to 500
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FIG. 2. Surface proteins of M. genitalium. Western blots of M.
genitalium proteins were incubated with (lane 1) surface-bound
rabbit antibodies eluted from a monolayer culture of M. genitalium
as described in Materials and Methods, (lane 2) unabsorbed rabbit
antiserum or (lane 3) normal preimmune rabbit serum. Blots were
imaged with 1251-labeled immunoglobulin G fraction of goat anti-
rabbit immunoglobulin G, and radioautographs were produced by
exposure to X-ray film at -70°C overnight.
jig/ml (Fig. 3A) and the incubation time extended up to 30
min (Fig. 3B), complete removal of MgPa was evident with
250 ,ug of trypsin per ml for 20 to 30 min. In addition, another
protein band with an estimated molecular mass of 108 kDa
was also lost in the trypsin-treated preparation. When a
Western blot prepared from an SDS-gel similar to that shown
in Fig. 3A was incubated with monoclonal antibody Mg-209,
the reactive epitope of MgPa was lost after treatment with
100 ,ug or more of trypsin per ml for 30 min (Fig. 3C). This
was accompanied by the appearance of a low-molecular-
weight band that was reactive with the antibody (most
prominent in lane 4 of Fig. 3C), indicating removal of this
epitope from MgPa by trypsin. The increased prominence of
the new band (lane 4) may be due to exposure by trypsin of
more accessable reactive sites than are present in the intact
MgPa molecule. The reactive residue diminished with in-
creased amounts of trypsin (Fig. 3C, lanes 5 and 6). To-
gether, these data indicate that MgPa is sensitive to trypsin
under the experimental conditions used. Technical differ-
ences may explain recently published information suggesting
that the 140-kDa protein of M. genitalium is insensitive to
the effects of trypsin (24). The differing sensitivities of MgPa
of M. genitalium and P1 of M. pneumoniae to trypsin
treatment implies that these proteins, although serologically
related, could be significantly distinct in terms of their
physicochemical properties. Nevertheless, this observation
adds additional evidence that MgPa is surface exposed.
Electron microscopy and immunostaining. Electron mi-
croscopy of negatively stained organisms revealed that sin-
gle M. genitalium cells were flask shaped (Fig. 4A), with a
well-demarcated outer layer of nap covering approximately
one-third of the cell at the differentiated terminus. This
confirms features described previously by Tully et al. (30,
31). The nap structure is similar to that described in M.
pneumoniae (12), but is much more extensive in area. When
M. genitalium was incubated with one of the monoclonal
antibodies (Mg-209) specific to MgPa followed by ferritin-
conjugated rabbit antibody to mouse immunoglobulins, the
monoclonal antibody reacted only with the region covered
by the nap structure (Fig. 4B). A monoclonal antibody
(M-525) specific to P1 protein of M. pneumoniae and previ-
ously shown to cross-react with protein MgPa of M.
genitalium by immunoblotting (7) also was used for im-
munostaining; identical results were observed (Fig. 4C).
When either of the monoclonal antibodies was omitted in the
immunostaining procedure, binding of the ferritin-labeled
second antibody was not evident (Fig. 4D). Thus, it appears
that MgPa and P1 share both immunologic relatedness and
association with the terminal organelle surface nap.
Immunogenicity of MgPa. Previous studies indicated that
the P1 protein of M. pneumoniae is a major immunogen,
since antibodies specific to P1 can be demonstrated in sera of
both hamsters infected with M. pneumoniae by inhalation
and human patients with natural infection (14, 16). Similar
results supporting the role of P1 protein as an immunodomin-
ant antigen were reported by Leith et al. (20). Moreover,
antibodies specific to P1 of both immunoglobulin G and
secretory immunoglobulin A classes were demonstrated in
respiratory secretions from those human subjects examined,
suggesting its role in the stimulation of protective immunity
(14). Comparable studies on MgPa of M. genitalium have
been precluded due to the technical difficulty of isolating the
organism from patients and, in turn, the lack of sera or
secretions from culture-proven infections. Recently,
Morrison-Plummer et al. reported evidence that experimen-
tally infected chimpanzees developed antibodies to the
140-kDa protein of M. genitalium by using sera from two
animals in a radioimmunoprecipitation technique (24). Sera
from a third animal available to us from the same study (28)
were tested from MgPa antibody by the Western blot
method. Antibodies to several M. genitalium proteins devel-
oped by 8 weeks postinfection, including one at the gel
location of MgPa (Fig. 5A). To determine whether this is the
same protein recognized by monoclonal antibody Mg-209,
comparable blots were treated first with the chimpanzee
immune serum. After washing, Mg-209 was reacted with the
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FIG. 3. Electrophoretic analysis and immunoradioautographs of
M. genitalium proteins after trypsin treatment. (A) Monolayers of
glass-grown M. genitalium were incubated at 37°C for 30 min with
increasing trypsin concentrations of (lane 1) 0, (lane 2) 25, (lane 3)
50, (lane 4) 100, (lane 5) 250, and (lane 6) 500 ,ug/ml. Electrophoresis
was carried out in a 7% sodium dodecyl sulfate gel, and the gel was
stained with Coomassie blue. Complete removal of MgPa is seen in
lanes 5 and 6. (B) M. genitalium monolayer cultures treated with 250
p.g of trypsin per ml for (lane 2) 0, (lane 3) 5, (lane 4) 10, (lane 5) 20,
and (lane 6) 30 min at 37°C; lane 1 is an untreated control. The
absence ofMgPa band is evident in lanes 5 and 6. (C) A Western blot
prepared from a gel similar to that in A was incubated with
monoclonal antibody Mg-209 and imaged with 1251I-labeled goat
anti-mouse immunoglobulins. Loss of reactive sites at the position
of the MgPa band is clearly seen in lanes 4 through 6, and residues
recognized by the antibody appear near the bottom of the blot.
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FIG. 4. Electron micrographs of M. genitalium. (A) Negative staining of an intact mycoplasma cell with ammonium molybdate. Note the
terminus is covered with a nap extending peripherally to the area marked by arrowheads. (B) Thin section of M. genitalium organisms after
incubation with monoclonal antibody (Mg-209) and indirect staining with ferritin-conjugated rabbit antibody to mouse immmunoglobulin G.
The lower three organisms were attached to a cover slip surface represented by the thin horizontal line. Ferritin grains are clustered around
the tip terminal corresponding to the area covered with the nap as shown in A. (C) Thin section of M. genitalium prepared in the same manner
as (B), but incubated with a monoclonal antibody (M-525) specific to the P1 protein of M. pneumoniae. (D) Thin section of M. genitalium
prepared in the same manner as B, but monoclonal antibody was omitted to serve as a negative control. Bars, 0.1 ,um.
the immunoreactive sites recognized by Mg-209 (Fig. 5B).
These data, other chimpanzee studies cited (24), recognition
by immunized rabbits, and ease of monoclonal antibody
production in mice suggest that MgPa is a significant im-
munogen of M. genitalium.
DISCUSSION
Several pathogenic Mycoplasma species including M.
pneumoniae and M. genitalium have biologic features in
common, of which the terminal tip structure (12, 19, 22, 28),
adhesive properties (1, 6, 30, 31), and gliding motility (4, 25)
appear the most striking. It is possible that these two
Mycoplasma species may share proteins with biologic and
immunologic similarities and parasitize host cells in like
fashion. However, discrepancies exist in published studies
seeking evidence of serologic cross-reactivity. Taylor-
Robinson et al. (29) reported that there was little or no
serologic cross-reaction between the human pathogens M.
genitalium and M. pneumoniae by the metabolic inhibition
test. In contrast, prominent cross-reactions were demon-
strated between these two species by Lind (21) with a variety
of serologic assays including the metabolic inhibition test.
Using hyperimmune rabbit sera against M. pneumoniae, M.
genitalium, and Mycoplasma gallisepticum in combination
with immunoblotting, we have shown extensive serological
cross-reactivities among these three species (11). However,
this evidence does not necessarily imply that the cross-
reactive proteins are identical or that they possess similar
biologic functions, because the protein profiles of these two
mycoplasma species have been shown to be markedly dif-
ferent from each other (3, 7).
An important virulence component of M. penumoniae is
the surface protein P1, which mediates initial attachment of
organisms to respiratory epithelium (3, 9, 12, 13). This
specific attachment has been recognized as the prerequisite
for colonization and subsequent development of M. pneu-
moniae disease in the lung (26). In view of the common
morphologic and biologic features shared by M. pneumo-
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FIG. 5. Immunogenicity of MgPa. (A) Western blots prepared
from M. genitalium separated on a 7% sodium dodecyl sulfate gel
were probed with chimpanzee preimmune serum (lane 1) or immune
serum (lane 2) and imaged with 251I-labeled goat anti-human immu-
noglobulin G. Lane 4 is a similar blot incubated with monoclonal
antibody (Mg-209) specific to MgPa (Fig. 1) and imaged with
'25I-labeled goat anti-mouse immunoglobulins. Lane 3 is a Western
blot prepared from trypsin-treated M. genitalium monolayer cul-
tures probed with chimpanzee immune serum. Loss of reactivity
with MgPa at the 140-kDa position and another immunoreactive
band at approximately the 108-kDa position is evident, indicating
both are surface-exposed proteins. (B) Western blots similar to
those in A were preincubated with chimpanzee preimmune serum
(lane 1), immune serum (lane 2), or incubation buffer only (lane 3),
washed, and then probed with monoclonal Mg-209 and imaged with
goat anti-mouse immunoglobulins. Significantly reduced intensity of
the 140-kDa band in lane 2 indicates the blocking of antigenic sites
for monoclonal Mg-209 by the chimpanzee immune serum.
role of P1 protein in the pathogenesis of M. pneumoniae
disease, it is pertinent to examine the possibility that M.
genitalium and M. gallisepticum may possess a surface
protein with function similar to the P1 protein of M. pneu-
moniae. Using a large collection of monoclonal antibodies,
we were able to demonstrate that a monoclonal antibody
specifically raised against P1 protein of M. pneumoniae was
capable of reacting with a smaller protein of M. genitalium,
and that monospecific antibodies raised by immunization of
a rabbit with P1 protein reacted with a similar-sized protein
of M. gallisepticum (7). These findings are compatible with
our hypothesis that these flask-shaped pathogenic Myco-
plasma species may parasitize their target host cells by
similar mechanisms.
Previous efforts of others to demonstrate epitopes of M.
pneumoniae P1 protein shared by M. genitalium and M.
gallisepticum proteins were unsuccessful, probably due to
the limited number of monoclonal antibodies used (3). How-
ever, a more recent study from the same laboratory reports
similarities between the P1 protein and a 140-kDa protein of
M. genitalium. The present report confirms this finding and
provides evidence that the 140-kDa protein, which is desig-
nated MgPa, is surface exposed and located over the termi-
nal structure of M. genitalium. The physical and immuno-
logical data imply that the MgPa protein of M. genitalium
could be a counterpart of P1 in M. pneumoniae and might
play a similar role in the pathogenesis of M. genitalium
infections. It has been shown that attachment of M.
genitalium to monkey kidney cells appeared to be mediated
by the nap (31). However, the establishment of a more
appropriate target cell model derived from human urogenital
tract tissue will be essential to confirm the role of MgPa in
attachment to natural host cells.
Another important aspect concerning the role of MgPa in
disease pathogenesis is its immunogenicity for the host. We
have shown that P1 protein of M. pneumoniae is recognized
by all patients examined during recovery from natural infec-
tions, through the development of specific antibodies to it in
sera and respiratory secretions (14). This immunologic prop-
erty may have importance in protective immunity. Lack of
comparable specimens from patients infected with M.
genitalium have precluded similar observations, although
preliminary studies reported here and elsewhere (24) with
sera from experimentally infected chimpanzees suggest that
MgPa is probably among the major immunogens of the
organism; whether MgPa is as immunodominant as P1 of M.
pneumoniae remains to be established.
Epidemiologic investigations of M. genitalium infections
have been limited by the poor recovery of organisms with
conventional culture systems and the possible nonspecificity
of serologic reactions. The availability of monoclonal anti-
bodies specific to MgPa and other M. genitalium proteins
may aid in the development of improved diagnostic methods
for the detection of M. genitalium in clinical samples. This
effort should allow us to determine whether M. genitalium
has a significant role in nongonococcal urethritis and pelvic
inflammatory disease and the relationship of M. genitalium
to other microorganisms isolated from patients with nongon-
ococcal urethritis.
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